I agree that this site is using cookies. You can find further informations here.
X
Havrdova, Eva Kubala
518  results:
Search for persons X
?
1

No evidence for association between rs10191329 severity loc..:

Campagna, Maria Pia ; Havrdova, Eva Kubala ; Horakova, Dana...
Multiple Sclerosis Journal.  , 2024
Link: https://doi.org/10.1177/..
 
?
2

Long-term clinical outcomes in patients with multiple scler..:

Butzkueven, Helmut ; Kalincik, Tomas ; Patti, Francesco...
Therapeutic Advances in Neurological Disorders.  17 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
3

Natalizumab promotes anti-inflammatory and repair effects i..:

Lereim, Ragnhild Reehorst ; Nytrova, Petra ; Guldbrandsen, Astrid...
PLOS ONE.  19 (2024)  3 - p. e0300914 , 2024
Link: https://doi.org/10.1371/..
 
?
4

Patients with multiple sclerosis who develop immunogenicity..:

Coelewij, Leda ; Adriani, Marsilio ; Dönnes, Pierre...
Clinical Immunology.  267 (2024)  - p. 110339 , 2024
Link: https://doi.org/10.1016/..
 
?
5

MRI and Clinical Outcomes of Evobrutinib, a Bruton's Tyrosi..:

Vermersch, Patrick ; Arnold, Douglas L ; Wolinsky, Jerry...
Multiple Sclerosis and Related Disorders.  71 (2023)  - p. 104360 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Is breastfeeding in MS harmful or not? An answer from real-..:

Hradilek, Pavel ; Zapletalova, Olga ; Hanulikova, Petra...
Multiple Sclerosis and Related Disorders.  76 (2023)  - p. 104790 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Variability of the response to immunotherapy among subgroup..:

Diouf, Ibrahima ; Malpas, Charles B. ; Sharmin, Sifat...
European Journal of Neurology.  30 (2023)  4 - p. 1014-1024 , 2023
Link: https://doi.org/10.1111/..
 
?
8

Time to Qualifying Relapse by Previous Disease-Modifying Th..:

Patti, Francesco ; Brochet, Bruno ; Havrdová, Eva Kubala...
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105331 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Comparative effectiveness in multiple sclerosis: A methodol..:

Roos, Izanne ; Diouf, Ibrahima ; Sharmin, Sifat...
Multiple Sclerosis Journal.  29 (2023)  3 - p. 326-332 , 2023
Link: https://doi.org/10.1177/..
 
?
10

Design and Baseline Characteristics of Phase 3, Double-Blin..:

Montalban, Xavier ; Vermersch, Patrick ; Arnold, Douglas L....
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105328 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Tract-wise microstructural analysis informs on current and ..:

Ravano, Veronica ; Piredda, Gian Franco ; Krasensky, Jan...
Journal of Neurology.  , 2023
Link: https://doi.org/10.1007/..
 
?
12

Diagnostic delay of multiple sclerosis: prevalence, determi..:

Uher, Tomas ; Adzima, Adrian ; Srpova, Barbora...
Multiple Sclerosis Journal.  29 (2023)  11-12 - p. 1437-1451 , 2023
Link: https://doi.org/10.1177/..
 
?
13

Early non-disabling relapses are important predictors of di..:

Daruwalla, Cyrus ; Shaygannejad, Vahid ; Ozakbas, Serkan...
Multiple Sclerosis Journal.  29 (2023)  7 - p. 875-883 , 2023
Link: https://doi.org/10.1177/..
 
?
14

Real-world operation of multiple sclerosis centres in Centr..:

Kokas, Zsófia ; Járdánházy, Anett ; Sandi, Dániel...
Multiple Sclerosis and Related Disorders.  69 (2023)  - p. 104406 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Expert opinion on the long-term use of cladribine tablets f..:

Oreja-Guevara, Celia ; Brownlee, Wallace ; Celius, Elisabeth G....
Multiple Sclerosis and Related Disorders.  69 (2023)  - p. 104459 , 2023
Link: https://doi.org/10.1016/..
 
1-15